Publications

David B Price, Sen Yang, Simon Wan Yau Ming, Antony Hardjojo, Claudia Cabrera, Andriana I Papaioannou, Stelios Loukides, Vicky Kritikos, Sinthia Z Bosnic-Anticevich, Victoria Carter, Paul M Dorinsky.Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation. Int J Chron Obstruct Pulmon Dis 2018; 13: 3937—3946.
[Full Text]

Jonathan Grigg, Anjan Nibber, James Y. Paton, Alison Chisholm, Theresa W. Guilbert, Alan Kaplan, Steve Turner, Nicolas Roche, Elizabeth V. Hillyer, David B. Price, Respiratory Effectiveness Group. Matched cohort study of therapeutic strategies to prevent preschool wheezing/asthma attacks. J Asthma Allergy 2018; 11: 309—321.
[Full Text]

Jaco Voorham, Xiao Xu, David Price, Sarowar Golam, Jill Davis 5, Joanna Ling Zhi Jie, Marjan Kerkhof, Mandy Ow, Trung N. Tran. Health care resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma. Allergy 2018.
[PubMed] [FullText]

Jaco Voorham, Nicolas Roche, Hicham Benhaddi, Marianka van der Tol, Victoria Carter, Job F.M. van Boven, Leif Bjermer, Marc Miravitlles, David B Price. Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK. BMJ Open 2018; 8(10): e022051.
[PubMed] [Full Text]

David B Price, Frank Trudo, Jaco Voorham, Xiao Xu,4 Marjan Kerkhof,Joanna Ling Zhi Jie, Trung N Tran5. Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study. J Asthma Allergy 2018; 11: 193—204.
[PubMed] [Full Text]

David B Price, Pete K Smith, Richard John Harvey, A Simon Carney, Vicky Kritikos, Sinthia Z Bosnic Anticevich, Louise Christian, Derek Skinner, Victoria Carter, Alice MS Durieux. Real-life treatment of rhinitis in Australia; a historical cohort study of prescription and over-the-counter therapies. Pragmat Obs Res 2018; 9: 43-54.
[PubMed] [Full Text]

Gene Colice, Alison Chisholm, Alexandra L Dima, Helen K Reddel, Annie Burden, Richard J Martin, Guy Brusselle, Todor A Popov, Julie von Ziegenweidt, David B Price. Performance of database-derived severe exacerbations and asthma control measures in asthma: responsiveness and predictive utility in a UK primary care database with linked questionnaire data. Pragmat Obs Res 2018; 9: 29-42.
[PubMed] [Full Text]

Marjan Kerkhof, Trung N. Tran, Maarten van den Berge, Guy G. Brusselle, Gokul Gopalan, Rupert C. M. Jones, Janwillem W. H. Kocks, Andrew Menzies-Gow, Javier Nuevo, Ian D. Pavord, Sarang Rastogi, David B. Price. Association between blood eosinophil count and risk of readmission for patients with asthma: historical cohort study. PLoS One 2018; 13(7): e0201143.
[PubMed] [Full Text]

Steve W Turner, Clare Murray, Mike Thomas, Annie Burden & David B Price. Applying UK real-world primary care data to predict asthma attacks in 3776 well-characterised children: a retrospective cohort study. npj Prim Care Respir Med 2018; 28(1): 28.
[PubMed] [Full Text]

David B. Price, Vicky Thomas, P. N. Richard Dekhuijzen, Sinthia Bosnic-Anticevich, Nicolas Roche, Federico Lavorini, Priyanka Raju, Daryl Freeman, Carole Nicholls, Iain R. Small, Erika Sims, Guilherme Safioti, Janice Canvin, Henry Chrystyn. Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: The Easy Low Instruction Over Time (ELIOT) study. BMC Pulm Med 2018; 18: 107.
[PubMed] [Full Text]

Joan B Soriano, Sarah Lucas, Rupert Jones, Marc Miravitlles, Victoria Carter, Iain Small, David Price, Ravi Mahadeva. Trends of testing for and diagnosis of alpha-1 antitrypsin deficiency in the UK: more testing is needed. Eur Respir J 2018; 52(1): 1800360.
[PubMed] [Full Text]

Alberto Papi, Dermot Ryan, Joan B. Soriano, Henry Chrystyn, Leif Bjermer, Roberto Rodríguez-Roisin, Myrna B. Dolovich, Mark Harris, Lucy Wood, Maria Batsiou, Susannah I. Thornhill, David B. Price. Relationship of Inhaled Corticosteroid Adherence to Asthma Exacerbations in Patients with Moderate-to-Severe Asthma. J Allergy Clin Immunol Pract 2018; 6(6): 1989-1998.e3.
[PubMed] [Full Text]

David B. Price, Eran Gefen, Gokul Gopalan, Rosie McDonald, Vicky Thomas, Simon Wan Yau Ming, Emily Davis. Real-life effectiveness and safety of Salbutamol Steri-neb™ vs. Ventolin Nebules® in preventing exacerbations in patients with COPD: historical cohort study. PLoS One 2018; 13(1): e0191404.
[PubMed] [Full Text]

Samatha Sonnappa, Brett McQueen, Dirkje S. Postma, Richard J. Martin, Nicolas Roche, Jonathan Grigg, Theresa Guilbert, Caroline Gouder, Emilio Pizzichini, Akio Niimi, Wanda Phipatanakul, Alison Chisholm, Ronald J. Dandurand, Alan Kaplan, Elliot Israel, Alberto Papi, Willem M.C. van Aalderen, Omar S. Usmani, David B. Price. Extrafine versus fine inhaled corticosteroids in relation to asthma control: a systematic review and meta-analysis of observational real-life studies. J Allergy Clin Immunol Pract 2017; 6(3): 907-915.e7.
[PubMed] [Full Text]

Marjan Kerkhof, Trung N Tran, Joan B Soriano, Sarowar Golam, Danny Gibson, Elizabeth V Hillyer, David B Price. Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population. Thorax 2018; 73: 116-124.
[PubMed] [Full Text]

Sinthia Bosnic-Anticevich, Christina Callan, Henry Chrystyn, Federico Lavorini, Vasilis Nikolaou, Vicky Kritikos, PN Richard Dekhuijzen, Nicolas Roche, Leif Bjermer, Cynthia Rand, Nicholas Zwar, David B Price. Inhaler technique mastery and maintenance in healthcare professionals trained on different devices. J Asthma 2018: 55(1): 79-88.
[PubMed] [Full Text]

Michael Schatz, Scott H. Sicherer, Robert S. Zeiger. “The Journal of Allergy and Clinical Immunology: In Practice 2017 Year in Review”. J Allergy Clin Immunol Pract 2018; 6(2): 328-352.
[PubMed] [Full Text]

Thys van der Molen, Monica Fletcher, and David Price. Identifying patient attitudinal clusters associated with asthma control: the European REALISE survey. J Allergy Clin Immunol Pract 2017.
[PubMed] [Full Text]

David B Price, Roland Buhl, Adrian Chan, Daryl Freeman, Elizabeth Gardener, Clifford Godley, Kevin Gruffydd-Jones, Lorcan McGarvey, Ken Ohta, Dermot Ryan, Jörgen Syk, Ngiap Chuan Tan, TzeLee Tan, Mike Thomas, Sen Yang, Priyanka Raju Konduru, Marcus Ngantcha, Martina Stagno d’Alcontres, Therese S Lapperre. Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial. Lancet Respir Med 2017.
[PubMed] [Full Text]

A Simon Carney, David B Price, Pete K Smith, Richard Harvey, Vicky Kritikos, Sinthia Z Bosnic-Anticevich, Louise Christian, Derek A Skinner, Victoria Carter, Alice MS Durieux. Seasonal patterns of oral antihistamine and intranasal corticosteroid purchases from Australian community pharmacies: a retrospective observational study. Pragmat Obs Res 2017; 8: 157-165.
[PubMed] [Full Text]

Rupert Jones, Jessica Martin, Vicky Thomas, Derek Skinner, Jonathan Marshall, Martina Stagno d’Alcontres, David Price. The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study. Int J Chron Obstruct Pulmon Dis 2017; 12: 2445-2454.
[PubMed] [Full Text]

Bosnic-Anticevich S, Kritikos V, Carter V, Yan KY, Armour C, Ryan D, Price D. Lack of asthma and rhinitis control in general practitioner-managed patients prescribed fixed dose combination therapy in Australia. J Asthma 2017; 8: 1-11.
[PubMed] [Full Text]

Simon Wan Yau Ming, John Haughney, Iain Small, Stephanie Wolfe, John Hamill, Kevin Gruffydd-Jones, Cathal Daly, Joan B. Soriano, Elizabeth Gardener, Derek Skinner, Martina Stagno d’Alcontres, David B. Price. Initiating or changing to a fixed-dose combination of fluticasone propionate/formoterol over fluticasone propionate/salmeterol: a real-life effectiveness and cost impact evaluation. Respir Med 2017; 129: 199-206.
[PubMed] [Full Text]

Samatha Sonnappa, Richard J. Martin, Elliot Israel, Dirkje Postma, Wim van Aalderen, Anne Burden, David B Price, Omar S. Usmani. Risk of pneumonia in obstructive lung disease: a real-life study comparing extra-fine and fine-particle inhaled corticosteroids. PLoS One 2017; 12(6): e0178112.
[PubMed] [Full Text]

David B Price, Eran Gefen, Gokul Gopalan, Cristiana Miglio, Rosie McDonald, Vicky Thomas, Simon Wan Yau Ming. Real-life effectiveness and safety of the inhalation suspension budesonide comparator vs the originator product for the treatment of patients with asthma: a historical cohort study using a US health claims database. Pragmat Obs Res 2017; 8: 69-83.
[PubMed] [Full Text]

Vicky Thomas, Eran Gefen, Gokul Gopalan, Rafael Mares, Rosie McDonald, Simon Wan Yau Ming, David B. Price. Ipratropium/Salbutamol comparator versus originator for chronic obstructive pulmonary disease exacerbations: US observational cohort study using the Clinformatics™ health claims database. Pulm Ther 2017; 3(1): 187-205.
[Full Text]

Dirkje S. Postma, Alan Kaplan, Joan B. Soriano, Jonathon Grigg, Theresa W. Guilbert, Wim van Aalderen, Nicolas Roche, Anne Burden, Elizabeth V. Hillyer, Elliot Israel, David B. Price. Cohort analysis of exacerbation rates in adolescent and adult patients initiating inhaled corticosteroids for asthma: different dose-response profile by particle size. Pulm Ther 2017; 3(1): 113-124.
[Full Text]

Smith P, Price D, Harvey R, Carney AS, Kritikos V, Bosnic-Anticevich SZ, Christian L, Skinner D, Carter V, Durieux AMS. Medication-related costs of rhinitis in Australia: a NostraData cross-sectional study of pharmacy purchases. J Asthma Allergy 2017; 10: 153-61.
[PubMed] [Full Text]

Jaco Voorham, Bernard Vrijens, Job FM van Boven, Dermot Ryan, Marc Miravitlles, Lisa M Law, David B Price. Does co-payment for inhaler devices affect therapy adherence and disease outcomes? A historical, matched cohort study. Pragmat Obs Res 2017; 8: 31-41.
[PubMed] [Full Text]

Omar S. Usmani, Anu Kemppinen, Elizabeth Gardener, Vicky Thomas, Priyanka Raju Konduru, Christina Callan, Andrew McLoughlin, Vanessa Woodhead, Adam Brady, Elizabeth F Juniper, Peter J Barnes, David B. Price. A randomized pragmatic trial of changing to and stepping down fluticasone/formoterol in asthma. J Allergy Clin Immunol Pract 2017; 5(5): 1378-1387.e5.
[PubMed] [Full Text]

Jens Dollerup, Jørgen Vestbo, Tarita Murray-Thomas, Alan Kaplan, Richard J Martin, Emilio Pizzichini, Marcia M M Pizzichini, Anne Burden, Jessica Martin, David B Price. Cardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study. Clin Epidemiol 2017; 9: 231-43.
[PubMed] [Full Text]

David B. Price, Miguel Román-Rodríguez, R. Brett McQueen, Sinthia Bosnic-Anticevich, Victoria Carter, Kevin Gruffydd-Jones, John Haughney, Svein Henrichsen, Catherine Hutton, Antonio Infantino, Federico Lavorini, Lisa M. Law, Karin Lisspers, Alberto Papi, Dermot Ryan, Björn Ställberg, Thys van der Molen, Henry Chrystyn. Inhaler errors in the CRITIKAL study: type, frequency, and association with asthma outcomes. J Allergy Clin Immunol Pract 2017; 5(4): 1071-81.e9.
[PubMed] [Full Text]

Clare S. Murray, Mike Thomas, Kathryn Richardson, David B. Price, Steve W. Turner. Comparative effectiveness of step-up therapies in children with asthma prescribed inhaled corticosteroids: a historical cohort study. J Allergy Clin Immunol Pract 2017; 5(4): 1082-1090.e7.
[PubMed] [Full Text]

Anne Burden, Nicolas Roche, Cristiana Miglio, Elizabeth V. Hillyer, Dirkje S. Postma, R. Brett McQueen, Ron M.C. Herings, Jetty A. Overbeek, Javaria Mona Khalid, Daniela van Eickels, Joan B. Soriano, David B. Price. An evaluation of exact matching and propensity score methods as applied in a comparative effectiveness study of inhaled corticosteroids in asthma. Pragmat Obs Res 2017; 8: 15-30.
[PubMed] [Full Text]

Theresa W. Guilbert, Gene Colice, Jonathan Grigg, Wim van Aalderen, Richard J. Martin, Elliot Israel, Dirkje S. Postma, Nicolas Roche, Wanda Phipatanakul, Elizabeth V. Hillyer, Jennifer M. Evans, Myrna B. Dolovich, David B. Price; in collaboration with the Respiratory Effectiveness Group. Real-life outcomes for patients with asthma prescribed spacers for use with either extrafine- or fine-particle inhaled corticosteroids. J Allergy Clin Immunol Pract 2017; 5(4): 1040-1049.e4.
[PubMed] [Full Text]

Sinthia Bosnic-Anticevich, Henry Chrystyn, Richard W Costello, Myrna B Dolovich, Monica J Fletcher, Federico Lavorini, Roberto Rodríguez-Roisin, Dermot Ryan, Simon Wan Yau Ming, David B Price. The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes. Int J Chron Obstruct Pulmon Dis 2017; 12: 59-71.

[PubMed] [Full Text]

Dirkje S. Postma, Richard Dekhuijzen, Thys van der Molen, Richard J. Martin, Wim van Aalderen, Nicolas Roche, Theresa W. Guilbert, Elliot Israel, Daniela van Eickels, Javaria Mona Khalid, Ron M.C. Herings, Jetty A. Overbeek, Cristiana Miglio, Victoria Thomas, Catherine Hutton, Elizabeth V. Hillyer, David B. Price. Asthma-related outcomes in patients initiating extrafine ciclesonide or fine-particle inhaled corticosteroids. Allergy Asthma Immunol Res 2017; 9(2): 116-25.
[PubMed] [Full Text]

Steve Turner, Kathryn Richardson, Clare Murray, Mike Thomas, Elizabeth V. Hillyer, Anne Burden, David B. Price; on behalf of the Respiratory Effectiveness Group. Long-acting β-agonist in combination or separate inhaler as step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. J Allergy Clin Immunol Pract 2017; 5(1): 99–106.e3.
[PubMed] [Full Text]

Samatha Sonnappa, Brett McQueen, Dirkje S. Postma, Richard J. Martin, Nicolas Roche, Jonathan Grigg, Theresa Guilbert, Caroline Gouder, Emilio Pizzichini, Akio Niimi, Wanda Phipatanakul, Alison Chisholm, Ronald J. Dandurand, Alan Kaplan, Elliot Israel, Alberto Papi, Willem M.C. van Aalderen, Omar S. Usmani, David B. Price. Extrafine versus fine inhaled corticosteroids in relation to asthma control: a systematic review and meta-analysis of observational real-life studies. J Allergy Clin Immunol Pract 2017.

Elizabeth V. Hillyer, David B. Price, Henry Chrystyn, Richard J. Martin, Elliot Israel, Willem M.C. van Aalderen, Alberto Papi, Omar S. Usmani, Nicolas Roche; on behalf of the Respiratory Effectiveness Group, Small Airways Study Group. Harmonizing the nomenclature for therapeutic aerosol particle size. J Aerosol Med Pulm Drug Deliv 2017; 31: 1-3.

Marjan Kerkhof, Elizabeth V. Hillyer, David B. Price. Reply [The effect of smoking on exacerbation risk in eosinophilic patients with chronic obstructive pulmonary disease]. Eur Respir J 2017; 50: 1702086.
[PubMed] [Full Text]

Marjan Kerkhof, Samatha Sonnappa, Dirkje S. Postma, Guy Brusselle, Alvar Agustí, Antonio Anzueto, Rupert Jones, Alberto Papi, Ian Pavord, Emilio Pizzichini, Todor Popov, Nicolas Roche, Dermot Ryan, Mike Thomas, Claus Vogelmeier, Alison Chisholm, Daryl Freeman, Mona Bafadhel, Elizabeth V. Hillyer and David B. Price. Blood eosinophil count and exacerbation risk in patients with COPD. Eur Respir J 2017; 50(1): 1700761.
[PubMed] [Full Text]

Theresa W. Guilbert, David B. Price. Reply [Impact of spacers on therapeutic ratio with inhaled corticosteroids]. J Allergy Clin Immunol Pract 2017; 5(4): 1163-4.
[Full Text]

John D Blakey, David B Price, Emilio Pizzichini, Todor A Popov, Borislav D Dimitrov, Dirkje S. Postma, Lynn K. Josephs, Alan Kaplan, Alberto Papi, Marjan Kerkhof, Elizabeth V Hillyer, Alison Chisholm, Mike Thomas. Identifying risk of future asthma attacks using UK medical record data: a Respiratory Effectiveness Group initiative. J Allergy Clin Immunol 2016; 5(4): 1015-1024.e8.
[PubMed] [Full Text]

P.N. Richard Dekhuijzen, Maria Batsiou, Leif Bjermer, Sinthia Bosnic-Anticevich, Henry Chrystyn, Alberto Papi, Roberto Rodríguez-Roisin, Monica Fletcher, Lucy Wood, Alessandra Cifra, Joan B. Soriano, David B. Price. Incidence of oral thrush in patients with COPD prescribed inhaled corticosteroids: effect of drug, dose, and device. Respir Med 2016; 120: 54-63.
[PubMed] [Full Text]

David M. G. Halpin, Marjan Kerkhof, Joan B. Soriano, Helga Mikkelsen, David B. Price. Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy. Respir Res 2016; 17(1): 120.
[PubMed] [Full Text]

David B. Price, Richard Russell, Rafael Mares, Anne Burden, Derek Skinner, Helga Mikkelsen, Cherlyn Ding, Richard Brice, Niels H. Chavannes, Janwillem W. H. Kocks, Jeffrey W. Stephens, John Haughney. Metabolic effects associated with ICS in patients with COPD and comorbid type 2 diabetes: a historical matched cohort study. PLoS One 2016; 11(9): e0162903.
[PubMed] [Full Text]

Manon Belhassen, Anjan Nibber, Eric Van Ganse, Dermot Ryan, Carole Langlois, Francis Appiagyei, Derek Skinner, Laurent Laforest, Joan B Soriano,David Price. Inappropriate asthma therapy — a tale of two countries: a parallel population-based cohort study. NPJ Prim Care Respir Med 2016; 26: 16076.
[PubMed] [Full Text]

David B Price, Anna Rigazio, Mary Buatti Small, Thomas J Ferro. Historical cohort study examining comparative effectiveness of albuterol inhalers with and without integrated dose counter for patients with asthma or chronic obstructive pulmonary disease. J Asthma Allergy 2016; 9: 145-54.
[PubMed] [Full Text]

David Price, Marc Miravitlles, Ian Pavord, Mike Thomas, Jadwiga Wedzicha, John Haughney, Katsiaryna Bichel, Daniel West. First maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis. NPJ Prim Care Respir Med 2016; 26: 16061.
[PubMed] [Full Text]

Brian Lipworth, Derek Skinner, Graham Devereux, Victoria Thomas, Joanna Ling Zhi Jie, Jessica Martin, Victoria Carter, David B Price. Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease. Heart 2016; 102(23): 1909-14.
[PubMed] [Full Text]

Thys van der Molen, Dirkje S. Postma, Richard J. Martin, Ron M.C. Herings, Jetty A. Overbeek, Victoria Thomas, Cristiana Miglio, Richard Dekhuijzen, Nicolas Roche, Theresa Guilbert, Elliot Israel, Wim van Aalderen, Elizabeth V. Hillyer, Simon van Rysewyk, David B. Price. Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands. BMC Pulm Med 2016; 16(1): 80.
[PubMed] [Full Text]

David B Price, Glenis Scadding, Claus Bachert, Hesham Saleh, Shuaib Nasser, Victoria Carter, Julie von Ziegenweidt, Alice MS Durieux, Dermot Ryan. UK prescribing practices as proxy markers of unmet need in allergic rhinitis: a retrospective observational study. NPJ Prim Care Respir Med 2016; 26:16033.
[PubMed] [Full Text]

Michael Happich, Noam Y. Kirson, Urvi Desai, Sarah King, Howard G. Birnbaum, Catherine Reed, Mark Belger, Alan Lenox-Smith, David Price. Excess costs associated with possible misdiagnosis of Alzheimer’s disease among patients with vascular dementia in a UK CPRD population. J Alzheimers Dis 2016; 53(1): 171–83.
[PubMed] [Full Text]

David B. Price, Gene Colice, Elliot Israel, Nicolas Roche, Dirkje S. Postma, Theresa W. Guilbert, Willem M.C. van Aalderen, Jonathan Grigg, Elizabeth V. Hillyer, Vicky Thomas, Richard J. Martin. Add-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhaler. ERJ Open Res 2016; 2(2).
[Full Text]

Nicolas Roche, Gene Colice, Elliot Israel, Richard J. Martin, Paul M. Dorinsky, Dirkje S. Postma, Theresa W. Guilbert, Jonathan Grigg, Willem M. C. van Aalderen, Francesca Barion, Elizabeth V. Hillyer, Victoria Thomas, Anne Burden, R. Brett McQueen, David B. Price. Cost-effectiveness of asthma step-up therapy as an increased dose of extrafine-particle inhaled corticosteroid or add-on long-acting beta2-agonist. Pulm Ther 2016; 2: 73-89.
[Full Text]

Henry Chrystyn, David B. Price, Mathieu Molimard, John Haughney, Sinthia Bosnic-Anticevich, Federico Lavorini, John Efthimiou, Dawn Shan, Erika Sims, Anne Burden, Catherine Hutton, Nicolas Roche. Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study. BMC Pulm Med 2016; 16(1):12.
[PubMed] [Full Text]

Kevin Gruffydd-Jones, Guy Brusselle, Rupert Jones, Marc Miravitlles, Michael Baldwin, Rebecca Stewart, Anna Rigazio, Emily Davis, Dorothy L Keininger, David Price. Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: in UK primary care: a real-world, retrospective, observational. NPJ Prim Care Respir Med 2016; 26: 16002.
[Full Text]

David Price, Andrew M Wilson, Alison Chisholm, Anna Rigazio, Anne Burden, Michael Thomas, Christine King. Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice. J Asthma Allergy 2016; 9: 1-12.
[PubMed] [Full Text]

Janine A.M. Westerik, Victoria Carter, Henry Chrystyn, Anne Burden, Samantha L. Thompson, Dermot Ryan, Kevin Gruffydd-Jones, John Haughney, Nicolas Roche, Federico Lavorini, Alberto Papi, Antonio Infantino, Miguel Román-Rodríguez, Sinthia Bosnic-Anticevich, Karin Lisspers, Björn Ställberg, Svein Høegh Henrichsen, Thys van der Molen, Catherine Hutton, David B. Price. Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting. J Asthma 2016; 53(3): 321-9.
[PubMed] [Full Text]

David B. Price, Job F. M. van Boven, Lisa M. Law, Alessandra Cifra, R. Brett McQueen. Cost comparison of asthma treatments in 12-week study: caution about matching and short observational follow-up. Multidiscip Respir Med 2016; 11: 39.
[Full Text]

David B Price, Ian D Pavord, Mike Thomas, Christopher J Corrigan, Andrew M Wilson, Elizabeth V Hillyer, Marjan Kerkhof. Inhaled corticosteroid dose-response on blood eosinophils in asthma – Authors’ reply. Lancet Respir Med 2016; 4(1): e1-2.
[PubMed] [Full Text]

Willem M. C. van Aalderen, Jonathan Grigg, Theresa W. Guilbert, Nicolas Roche, Gene Colice, Dirkje S. Postma, Elizabeth V. Hillyer, David B. Price. Reply [Inhaled corticosteroids for asthma therapy in young children: does aerosol particle size matter?]. J Allergy Clin Immunol Pract 2016; 4(2): 372-3.
[Full Text]

Marjan Kerkhof, Daryl Freeman, Rupert Jones, Alison Chisholm, David B Price; on behalf of the Respiratory Effectiveness Group. Predicting frequent COPD exacerbations using primary care data. Int J Chron Obstruct Pulmon Dis 2015; 10: 2439-50.
[PubMed] [Full Text]

David B Price, Anna Rigazio, Jonathan D Campbell, Eugene R Bleecker, Christopher J Corrigan, Mike Thomas, Sally E Wenzel, Andrew M Wilson, Mary Buatti Small, Gokul Gopalan, Valerie L Ashton, Anne Burden, Elizabeth V Hillyer, Marjan Kerkhof, Ian D Pavord. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study. Lancet Respir Med 2015; 3(11): 849–58.
[PubMed] [Full Text]

Willem M.C. van Aalderen, Jonathan Grigg, Theresa W. Guilbert, Nicolas Roche, Elliot Israel, Richard J. Martin, Gene Colice, Dirkje S. Postma, Elizabeth V. Hillyer, Anne Burden, Victoria Thomas, Julie von Ziegenweidti, David Price. Small-particle inhaled corticosteroid as first-line or step-up controller therapy in childhood asthma. J Allergy Clin Immunol Pract 2015; 3(5): 721-31.e16.
[PubMed] [Full Text]

Steve W Turner, Kathryn Richardson, Annie Burden, Mike Thomas, Clare Murray, David Price. Initial step-up treatment changes in asthmatic children already prescribed inhaled corticosteroids: a historical cohort study. NPJ Prim Care Respir Med 2015; 25: 15041.
[PubMed] [Full Text]

Elliot Israel, Nicolas Roche, Richard J. Martin, Gene Colice, Paul M. Dorinsky, Dirkje S. Postma, Theresa W. Guilbert, Willem M. C. van Aalderen, Jonathan Grigg, Elizabeth V. Hillyer, Anne Burden, Julie von Ziegenweidt, Victoria Thomas, David B. Price. Increased dose of inhaled corticosteroid versus add-on long-acting β-agonist for step-up therapy in asthma. Ann Am Thorac Soc 2015; 12(6): 798-806.
[PubMed] [Full Text]

David Price, Alan Kaplan, Rupert Jones, Daryl Freeman, Anne Burden, Shuna Gould, Julie von Ziegenweidt, Muzammil Ali, Christine King, Mike Thomas. Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide. J Asthma Allergy 2015; 8: 1-13.
[PubMed] [Full Text]

David Price, Pete Smith, Peter Hellings, Nikos Papadopoulos, Wytske Fokkens, Antonella Muraro, Ruth Murray, Alison Chisholm, Pascal Demoly, Glenis Scadding, Joaquim Mullol, Phil Lieberman, Claus Bachert, Ralph Mösges, Dermot Ryan, Jean Bousquet. Current controversies and challenges in allergic rhinitis management. Expert Rev Clin Immunol 2015; 11(11): 1205-17.
[PubMed] [Full Text]

David Price, Henry Chrystyn. Concept review of dry powder inhalers: correct interpretation of published data. Multidiscip Respir Med 2015; 10:36.
[PubMed] [Full Text]

Nicolas Roche, Dirkje S. Postma, Gene Colice, Anne Burden, Theresa W. Guilbert, Elliot Israel, Richard J. Martin, Willem M. C. van Aalderen, Jonathan Grigg, Elizabeth V. Hillyer, Julie von Ziegenweidt, David B. Price. Differential effects of inhaled corticosteroids in smokers/ex-smokers and nonsmokers with asthma. Am J Respir Crit Care Med 2015; 191(8): 960-4.
[PubMed] [Full Text]

Richard J Martin, David Price, Nicolas Roche, Elliot Israel, Willem MC van Aalderen, Jonathan Grigg, Dirkje S Postma, Theresa W Guilbert, Elizabeth V Hillyer, Anne Burden, Julie von Ziegenweidt, Gene Colice. Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study. NPJ Prim Care Respir Med 2014; 24: 14081.
[PubMed] [Full Text]

Dirkje S Postma, Nicolas Roche, Gene Colice, Elliot Israel, Richard J Martin, Willem MC van Aalderen, Jonathan Grigg, Anne Burden, Elizabeth V Hillyer, Julie von Ziegenweidt, Gokul Gopalan, David Price. Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD. Int J Chron Obstruct Pulmon Dis 2014; 9: 1163-86.
[PubMed] [Full Text]

David Price, Daniel West, Guy Brusselle, Kevin Gruffydd-Jones, Rupert Jones, Marc Miravitlles, Andrea Rossi, Catherine Hutton, Valerie L Ashton, Rebecca Stewart, Katsiaryna Bichel. Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns. Int J Chron Obstruct Pulmon Dis 2014; 9: 889-904.
[PubMed] [Full Text]

Claire Brockwell, Sundari Ampikaipakan, Darren W Sexton, David Price, Daryl Freeman, Mike Thomas, Muzammil Ali, Andrew M Wilson. Adjunctive treatment with oral AKL1, a botanical nutraceutical, in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2014; 9: 715-21.
[PubMed] [Full Text]

David Price, Vicky Thomas, Julie von Ziegenweidt, Shuna Gould, Catherine Hutton, Christine King. Switching patients from other inhaled corticosteroid devices to the Easyhaler®: historical, matched-cohort study of real-life asthma patients. J Asthma Allergy 2014; 10(7): 31-51.
[PubMed] [Full Text]

Rupert C M Jones, David Price, Dermot Ryan, Erika J Sims, Julie von Ziegenweidt, Laurence Mascarenhas, Anne Burden, David M G Halpin, Robert Winter, Sue Hill, Matt Kearney, Kevin Holton, Anne Moger, Daryl Freeman, Alison Chisholm, Eric D Bateman, on behalf of The Respiratory Effectiveness Group. Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort. Lancet Respir Med 2014; 2(4): 267-76.
[PubMed] [Full Text]

David Price, Elizabeth V Hillyer. Fluticasone propionate/formoterol fumarate in fixed-dose combination for the treatment of asthma. Expert Rev Respir Med 2014; 8(3): 275-91.
[PubMed] [Full Text]

David Price, Dermot Ryan, Annie Burden, Julie Von Ziegenweidt, Shuna Gould, Daryl Freeman, Kevin Gruffydd-Jones, Anne Copland, Clifford Godley, Alison Chisholm, Mike Thomas. Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care. Clin Transl Allergy 2013; 3(1): 37.
[PubMed] [Full Text]

David Price, Iain Small, John Haughney, Dermot Ryan, Kevin Gruffydd-Jones, Federico Lavorini, Tim Harris, Annie Burden, Jeremy Brockman, Christine King, Alberto Papi. Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: a retrospective matched observational study of real-world patients. Prim Care Respir J 2013; 22(4): 439-48.
[PubMed] [Full Text]

David Price, Mike Thomas, John Haughney, Richard A. Lewis, Anne Burden, Julie von Ziegenweidt, Alison Chisholm, Elizabeth V. Hillyer, Christopher J. Corrigan. Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma. Respir Med 2013; 107(7): 987-1000.
[PubMed] [Full Text]

Gene Colice, Richard J. Martin, Elliot Israel, Nicolas Roche, Neil Barnes, Anne Burden, Peter Polos, Paul Dorinsky, Elizabeth V. Hillyer, Amanda J. Lee, Alison Chisholm, Julie von Ziegenweidt,Francesca Barion, David Price. Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone. J Allergy Clin Immunol 2013; 132(1): 45-54.
[PubMed] [Full Text]

David Price, Amanda J Lee, Erika J Sims, Linda Kemp, Elizabeth V Hillyer, Alison Chisholm, Julie von Ziegenweidt, Angela Williams. Characteristics of patients preferring once-daily controller therapy for asthma and COPD: a retrospective cohort study. Prim Care Respir J 2013; 22(2): 161-8.
[PubMed] [Full Text]

David Price, Alison Chisholm, Elizabeth V Hillyer, Annie Burden, Julie von Ziegenweidt, Henrik Svedsater, Peter Dale. Effect of inhaled corticosteroid therapy step-down and dosing regimen on measures of asthma control. J Allergy Ther 2013; 4(1): 126.

David Price, Elizabeth V. Hillyer, Thys van der Molen. Efficacy versus effectiveness trials: informing guidelines for asthma management. Curr Opin Allergy Clin Immunol 2013; 13(1): 50-7.
[PubMed] [Full Text]

David Price, Leif Bjermer, John Haughney, Nicolas Roche, Jean Bousquet, Elizabeth V. Hillyer, Alison Chisholm. Real-life asthma strategies: the missing piece in the jigsaw. Treatment Strategies – Respiratory 2013; 3(2): 37-46.

David Price, Henry Chrystyn, Alan Kaplan, John Haughney, Miguel Román-Rodríguez, Annie Burden, Alison Chisholm, Elizabeth V. Hillyer, Julie von Ziegenweidt, Muzammil Ali, Thys van der Molen. Effectiveness of same versus mixed asthma inhaler devices: a retrospective observational study in primary care. Allergy Asthma Immunol Res 2012; 4(4): 184-91.
[PubMed] [Full Text]

Erika J Sims, David Price. Spirometry: an essential tool for screening, case-finding, and diagnosis of COPD. Prim Care Respir J 2012; 21(2): 128-30.
[PubMed] [Full Text]

Barnes, D. Price, G. Colice, A. Chisholm, P. Dorinsky, E. V. Hillyer, A. Burden, A. J. Lee, R. J. Martin, N. Roche, J. von Ziegenweidt, E. Israel. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study. Clin Exp Allergy 2011; 41(11): 1521-32.
[PubMed] [Full Text]

David Price, Nicolas Roche, J. Christian Virchow, Annie Burden, Muzammil Ali, Alison Chisholm, Amanda J. Lee, Elizabeth V. Hillyer, Julie von Ziegenweidt. Device type and real-world effectiveness of asthma combination therapy: An observational study. Respir Med 2011; 105(10): 1457-66.
[PubMed] [Full Text]

David Price, Stanley D. Musgrave, Lee Shepstone, Elizabeth V. Hillyer, Erika J. Sims, Richard F.T. Gilbert, Elizabeth F. Juniper, Jon G. Ayres, Linda Kemp, Annie Blyth, Edward C.F. Wilson, Stephanie Wolfe, Daryl Freeman, H. Miranda Mugford, Jamie Murdoch, Ian Harvey. Leukotriene antagonists as first-line or add-on asthma-controller therapy. N Engl J Med 2011; 364(18): 1695-707.
[PubMed] [Full Text]

David Price, John Haughney, Erika Sims, Muzammil Ali, Julie von Ziegenweidt, Elizabeth V Hillyer, Amanda J Lee, Alison Chisholm, Neil Barnes. Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD. J Asthma Allergy 2011; 4: 37-47.
[PubMed] [Full Text]

David Price, Alison Chisholm, Thys van der Molen, Nicolas Roche, Elizabeth V. Hillyer, Jean Bousquet. Reassessing the evidence hierarchy in asthma: evaluating comparative effectiveness. Curr Allergy Asthma Rep 2011; 11(6): 526-38.
[PubMed] [Full Text]

Erika J Sims, David Price, John Haughney, Dermot Ryan, Mike Thomas. Current control and future risk in asthma management. Allergy Asthma Immunol Res 2011; 3(4): 217-25.
[PubMed] [Full Text]

David Price, Elizabeth F. Juniper, Elizabeth V. Hillyer. The authors reply [Leukotriene antagonists in asthma]. N Engl J Med 2011; 365(3): 273-4.
[Full Text]

David Price, Richard J. Martin, Neil Barnes, Paul Dorinsky, Elliot Israel, Nicolas Roche, Alison Chisholm, Elizabeth V. Hillyer, Linda Kemp, Amanda J. Lee, Julie von Ziegenweidt, Gene Colice. Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational study. J Allergy Clin Immunol 2010; 126(3): 511-8.e10.
[PubMed] [Full Text]

Edward C.F. Wilson, David Price, Stanley D. Musgrave, Erika J. Sims, Lee Shepstone, Jamie Murdoch, H. Miranda Mugford, Annie Blyth, Elizabeth F. Juniper, Jon G. Ayres, Stephanie Wolfe, Daryl Freeman, Richard F.T. Gilbert, Elizabeth V. Hillyer, Ian Harvey. Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trial. Pharmacoeconomics 2010; 28(7): 597-608.
[PubMed] [Full Text]

Edward C.F. Wilson, Erika J. Sims, Stanley D. Musgrave, Lee Shepstone, Annie Blyth, Jamie Murdoch, H. Miranda Mugford, Elizabeth F. Juniper, Jon G. Ayres, Stephanie Wolfe, Daryl Freeman, Richard F.T. Gilbert, Ian Harvey, Elizabeth V. Hillyer, David Price. Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trial. Pharmacoeconomics 2010; 28(7): 585-95.
[PubMed] [Full Text]

Linda Kemp, John Haughney, Neil Barnes, Erika Sims, Julie von Ziegenweidt, Elizabeth V Hillyer, Amanda J Lee, Alison Chisholm, David Price. Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational study. Clinicoecon Outcome Res 2010; 2: 75-85.
[PubMed] [Full Text]

David Price, Linda Kemp, Erika Sims, Julie von Ziegenweidt, Prakash Navaratnam, Amanda J Lee, Alison Chisholm, Elizabeth V Hillyer, Gokul Gopalan. Observational study comparing intranasal mometasone furoate with oral antihistamines for rhinitis and asthma. Prim Care Respir J 2010; 19(3): 266-73.
[PubMed] [Full Text]

David Price, Alison Chisholm, Dermot Ryan, Alan Crockett, Rupert Jones. The use of roflumilast in COPD: a primary care perspective. Prim Care Respir J 2010; 19(4): 342-51.
[PubMed] [Full Text]

Haughney, E. Sims, J. Holohan, D. Ryan, D. Price. Improving clinician-patient communication in asthma: the HARP project. Allergy 2010; 65(4): 413-4.
[PubMed] [Full Text]

Mike Thomas, David Price, Henry Chrystyn, Andrew Lloyd, Angela E Williams, Julie von Ziegenweidt. Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control. BMC Pul Med 2009; 9: 1.
[PubMed] [Full Text]

Mike Thomas, Julie von Ziegenweidt, Amanda J. Lee, David Price. High-dose inhaled corticosteroids versus add-on long-acting beta-agonists in asthma: an observational study. J Allergy Clin Immunol 2009; 123(1):116-21.e10.
[PubMed] [Full Text]

S Turner, M Thomas, J von Ziegenweidt, D Price. Prescribing trends in asthma: a longitudinal observational study. Arch Dis Child 2009; 94(1): 16-22.
[PubMed] [Full Text]